Planet Labs: Defense Growth Story Could Still Deliver, But There's A Catch (Upgrade)
Planet Labs is upgraded to a 'Buy' with a $48.11 price target, reflecting strong government and defense-driven growth. Q4 revenues hit a record $86.8 million, with 59% full-year gross margins and positive EBITDA and free cash flow, though margin compression is expected. FY27 guidance projects 35%-43% sales growth but lower gross margins (50%-52%) and flat-to-lower EBITDA as investments ramp up.
Planet Labs Brings Edge AI To Orbit Using Nvidia: More Upside Ahead
Planet Labs is transitioning from a data provider to a real-time geospatial intelligence platform, leveraging AI-powered, in-orbit analytics for higher-margin, recurring revenue. PL's Pelican-4 satellite demonstrates onboard AI object detection, enabling near-instant actionable insights and positioning the company for defense and intelligence contracts. Recent warrant redemption cleans up PL's capital structure, potentially improving liquidity and removing dilution overhang as shares trade near $40.
2 stocks to buy before SpaceX IPO
A potential SpaceX IPO continues to capture investor imagination, with expectations that the company could seek a valuation of up to $2 trillion.
Going Dark: A Strange Buy Signal from the Stars
In the fast-moving world of high-growth tech stocks, headlines can be deceiving. Recently, news broke that Planet Labs PBC NYSE: PL, a powerhouse in the satellite imagery sector, had complied with a U.S. government request to halt its data feed over a conflict zone in the Middle East.
Planet Labs Trades at a Premium: Should You Still Buy the Stock?
PL trades at a steep premium despite strong growth, rising backlog, and government deals, raising questions about whether the stock is still worth buying.
Planet Labs Stock Has Risen 765% in a Year and Wall Street Is Just Now Paying Attention
Operating the largest fleet of imaging satellites, Planet Labs (NYSE:PL) just delivered its first full fiscal year of profitability, and Reddit noticed immediately.
You're Up 150% On Planet Labs, What To Do Now?
Planet Labs delivered a strong 4Q26 beat, with accelerating demand and revenue of $86.8M, driving the stock up 25%. PL's FY26 revenue grew 26% YoY to $307.7M, with backlog and remaining performance obligations surging, supporting high revenue visibility and recurring contract durability. Profitability is emerging, highlighted by positive adjusted EBITDA of $15.5M and robust cash generation, though GAAP net loss remains due to non-cash charges.
Planet Labs Jumps 23% After Hours as Its $900M Backlog Finally Gets Wall Street's Attention
Planet Labs (NYSE:PL), a leading provider of global, daily satellite imagery and geospatial solutions, saw its shares jump 23% after hours on March 19 after the company posted its largest quarterly revenue ever and a backlog that now exceeds its entire annual revenue.
Planet Labs PBC (PL) Q4 2026 Earnings Call Transcript
Planet Labs PBC (PL) Q4 2026 Earnings Call Transcript
Planet Labs Crushes Earnings, But Risk Is Rising
Planet Labs delivered a standout Q4-2026, with 41% YoY revenue growth and a substantial beat on both revenue and EPS expectations. PL raised FY2027 revenue guidance to $415–440M, implying 38.9% YoY growth and signaling accelerating momentum, with backlog up 79% to $900.4M. Despite positive free cash flow and strong technical momentum, PL trades at a steep 23.9x forward sales, tempering long-term conviction.
Planet Labs: 500% Rally, Growth Case Still Intact
I still see Planet Labs PBC as a top-line growth story, with FY27 revenue guided to $415M-$440M and 67% of its $900M backlog converting over the next two years. PL's backlog was up 79% in the last fiscal year. I think there is more room for growth in the back half of this year. I believe the Defense & Intelligence segment is the key upside area, with FY26 revenue up 50% and potential tailwinds from the proposed $1.5 trillion U.S. defense budget for 2027.
Planet Labs strong Q4 prompts price target raise from Wedbush
Planet Labs (NYSE:PL) reported strong fourth quarter results and raised its fiscal year 2027 guidance, prompting Wedbush to maintain an ‘Outperform' rating and lift its price target from $30 to $40. Shares of Planet Labs surged almost 28% to about $34 on Friday morning.
